Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 6
1994 1
1996 1
1997 3
1998 3
2000 1
2003 1
2004 2
2006 1
2007 2
2008 2
2009 1
2011 1
2012 2
2013 1
2015 3
2016 3
2018 2
2019 2
2020 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
A marine sponge-derived lectin reveals hidden pathway for thrombopoietin receptor activation.
Watari H, Kageyama H, Masubuchi N, Nakajima H, Onodera K, Focia PJ, Oshiro T, Matsui T, Kodera Y, Ogawa T, Yokoyama T, Hirayama M, Hori K, Freymann DM, Imai M, Komatsu N, Araki M, Tanaka Y, Sakai R. Watari H, et al. Among authors: masubuchi n. Nat Commun. 2022 Nov 25;13(1):7262. doi: 10.1038/s41467-022-34921-2. Nat Commun. 2022. PMID: 36433967 Free PMC article.
Phase 1 Clinical Trial of PPMX-T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics.
Ogama Y, Kumagai Y, Komatsu N, Araki M, Masubuchi N, Akiyoshi H, Matsuura T, Kirisako H, Kyoya A, Nomura F, Ohira Y, Yokokawa T, Yamamoto Y. Ogama Y, et al. Among authors: masubuchi n. Clin Pharmacol Drug Dev. 2023 Jun;12(6):579-587. doi: 10.1002/cpdd.1216. Epub 2022 Dec 30. Clin Pharmacol Drug Dev. 2023. PMID: 36583544 Clinical Trial.
Skewed megakaryopoiesis in human induced pluripotent stem cell-derived haematopoietic progenitor cells harbouring calreticulin mutations.
Takei H, Edahiro Y, Mano S, Masubuchi N, Mizukami Y, Imai M, Morishita S, Misawa K, Ochiai T, Tsuneda S, Endo H, Nakamura S, Eto K, Ohsaka A, Araki M, Komatsu N. Takei H, et al. Among authors: masubuchi n. Br J Haematol. 2018 Jun;181(6):791-802. doi: 10.1111/bjh.15266. Epub 2018 May 9. Br J Haematol. 2018. PMID: 29741776 Free article.
Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor.
Nakamura Y, Fujimoto T, Ogawa Y, Sugita C, Miyazaki S, Tamaki K, Takahashi M, Matsui Y, Nagayama T, Manabe K, Mizuno M, Masubuchi N, Chiba K, Nishi T. Nakamura Y, et al. Among authors: masubuchi n. ACS Med Chem Lett. 2012 Aug 18;3(9):754-8. doi: 10.1021/ml300168e. eCollection 2012 Sep 13. ACS Med Chem Lett. 2012. PMID: 24900544 Free PMC article.
Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.
Miyagoe-Suzuki Y, Masubuchi N, Miyamoto K, Wada MR, Yuasa S, Saito F, Matsumura K, Kanesaki H, Kudo A, Manya H, Endo T, Takeda S. Miyagoe-Suzuki Y, et al. Among authors: masubuchi n. Mech Dev. 2009 Mar-Apr;126(3-4):107-16. doi: 10.1016/j.mod.2008.12.001. Epub 2008 Dec 16. Mech Dev. 2009. PMID: 19114101 Free article.
36 results